Advances in chemotherapy of non-small cell lung cancerMOLINA, Julian R; ADJEI, Alex A; JETT, James R et al.Chest. 2006, Vol 130, Num 4, pp 1211-1219, issn 0012-3692, 9 p.Article

Chemotherapy-induced ovarian failure : Manifestations and managementMOLINA, Julian R; BARTON, Debra L; LOPRINZI, Charles L et al.Drug safety. 2005, Vol 28, Num 5, pp 401-416, issn 0114-5916, 16 p.Article

Ranibizumab Combined With Low-Dose Sorafenib for Exudative Age-Related Macular DegenerationDIAGO, Teresa; PULIDO, Jose S; MOLINA, Julian R et al.Mayo Clinic proceedings. 2008, Vol 83, Num 2, pp 231-234, issn 0025-6196, 4 p.Article

Predictors of survival from urachal cancer : A mayo clinic study of 49 casesMOLINA, Julian R; FERNANDO QUEVEDO, J; FURTH, Alfred F et al.Cancer. 2007, Vol 110, Num 11, pp 2434-2440, issn 0008-543X, 7 p.Article

Tumor Response and Progression-Free Survival as Potential Surrogate Endpoints for Overall Survival in Extensive Stage Small-Cell Lung Cancer: Findings on the Basis of North Central Cancer Treatment Group TrialsFOSTER, Nathan R; YINGWEI QI; QIAN SHI et al.Cancer. 2011, Vol 117, Num 6, pp 1262-1271, issn 0008-543X, 10 p.Article

A Front-Line Window of Opportunity Phase 2 Study of Sorafenib in Patients With Advanced Nonsmall Cell Lung Cancer: North Central Cancer Treatment Group Study N0326DY, Grace K; HILLMAN, Shauna L; ROWLAND, Kendrith M et al.Cancer. 2010, Vol 116, Num 24, pp 5686-5693, issn 0008-543X, 8 p.Article

Gender differences in non-small-cell lung cancer survival: An analysis of 4,618 patients diagnosed between 1997 and 2002VISBAL, Antonio L; WILLIAMS, Brent A; MATHISEN, Douglas et al.The Annals of thoracic surgery. 2004, Vol 78, Num 1, pp 209-215, issn 0003-4975, 7 p.Article

A Multiinstitutional Phase 2 Trial of Pazopanib Monotherapy in Advanced Anaplastic Thyroid CancerBIBLE, Keith C; SUMAN, Vera J; LIM, Wan-Teck et al.The Journal of clinical endocrinology and metabolism. 2012, Vol 97, Num 9, pp 3179-3184, issn 0021-972X, 6 p.Article

Frequent methylation of Eyes absent 4 gene in Barrett's esophagus and esophageal adenocarcinomaHONGZHI ZOU; OSBORN, Neal K; HARRINGTON, Jonathan J et al.Cancer epidemiology, biomarkers & prevention. 2005, Vol 14, Num 4, pp 830-834, issn 1055-9965, 5 p.Article

Effect of Disrupting Seven-in-Absentia Homolog 2 Function on Lung Cancer Cell GrowthAHMED, Atique U; SCHMIDT, Rebecca L; TANG, Amy H et al.Journal of the National Cancer Institute. 2008, Vol 100, Num 22, pp 1606-1629, issn 0027-8874, 24 p.Article

Phase I trial of Sorafenib in combination with gefitinib in patients with refractory or recurrent non-small cell lung cancerADJEI, Alex A; MOLINA, Julian R; SIMANTOV, Ronit et al.Clinical cancer research. 2007, Vol 13, Num 9, pp 2684-2691, issn 1078-0432, 8 p.Article

A comprehensive search for DNA amplification in lung cancer identifies inhibitors of apoptosis cIAP1 and cIAP2 as candidate oncogenesZUNYAN DAI; ZHU, Wei-Guo; OTTERSON, Gregory A et al.Human molecular genetics (Print). 2003, Vol 12, Num 7, pp 791-801, issn 0964-6906, 11 p.Article

Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of TH-302, a Hypoxia-Activated Prodrug, in Patients with Advanced Solid MalignanciesWEISS, Glen J; INFANTE, Jeffrey R; LACOUTURE, Mario E et al.Clinical cancer research (Print). 2011, Vol 17, Num 9, pp 2997-3004, issn 1078-0432, 8 p.Article

Non-Small Cell Lung Cancer : Epidemiology, Risk Factors, Treatment, and SurvivorshipMOLINA, Julian R; PING YANG; CASSIVI, Stephen D et al.Mayo Clinic proceedings. 2008, Vol 83, Num 5, pp 584-594, issn 0025-6196, 11 p.Article

Primary salivary gland-type lung cancer : Spectrum of clinical presentation, histopathologic and prognostic factorsMOLINA, Julian R; AUBRY, Marie Christine; LEWIS, Jean E et al.Cancer. 2007, Vol 110, Num 10, pp 2253-2259, issn 0008-543X, 7 p.Article

Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagusHONGZHI ZOU; MOLINA, Julian R; HARRINGTON, Jonathan J et al.International journal of cancer. 2005, Vol 116, Num 4, pp 584-591, issn 0020-7136, 8 p.Article

A phase II trial of the Src-kinase inhibitor saracatinib after four cycles of chemotherapy for patients with extensive stage small cell lung cancer: NCCTG trial N-0621MOLINA, Julian R; FOSTER, Nathan R; REUNGWETWATTANA, Thanyanan et al.Lung cancer. 2014, Vol 85, Num 2, pp 245-250, issn 0169-5002, 6 p.Article

Adjuvant chemoradiation therapy with high-dose versus weekly cisplatin for resected, locally-advanced HPV/p16-positive and negative head and neck squamous cell carcinomaGEIGER, Jessica L; LAZIM, Ahmed F; MA, Daniel J et al.Oral oncology (1997). 2014, Vol 50, Num 4, pp 311-318, issn 1368-8375, 8 p.Article

Phase II Trial of Pemetrexed Plus Bevacizumab for Second-Line Therapy of Patients With Advanced Non-Small-Cell Lung Cancer: NCCTG and SWOG Study N0426ADJEI, Alex A; MANDREKAR, Sumithra J; ZINNER, Ralph G et al.Journal of clinical oncology. 2010, Vol 28, Num 4, pp 614-619, issn 0732-183X, 6 p.Article

Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral, Small-Molecule Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor AZD6244 (ARRY-142886) in Patients With Advanced CancersADJEI, Alex A; COHEN, Roger B; MALONEY, Lara et al.Journal of clinical oncology. 2008, Vol 26, Num 13, pp 2139-2146, issn 0732-183X, 8 p.Article

Evaluation of Lapatinib and Topotecan Combination Therapy : Tissue Culture, Murine Xenograft, and Phase I Clinical Trial DataMOLINA, Julian R; KAUFMANN, Scott H; JEWELL, Roxanne C et al.Clinical cancer research (Print). 2008, Vol 14, Num 23, pp 7900-7908, issn 1078-0432, 9 p.Article

Phase I dose escalation study of the anti-insulin-like growth factor-I receptor monoclonal antibody CP-751,871 in patients with refractory solid tumorsHALUSKA, Paul; SHAW, Heather M; ADJEI, Alex A et al.Clinical cancer research. 2007, Vol 13, Num 19, pp 5834-5840, issn 1078-0432, 7 p.Article